# Long-term Follow-up of Patients With Chronic Kidney Disease Who Had Administered Cellgram-CKD in PMC-P-12 Study

> **NCT05096182** · — · ACTIVE_NOT_RECRUITING · sponsor: **Pharmicell Co., Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Renal Insufficiency, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05096182
- **Lead sponsor:** Pharmicell Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-10
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05096182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05096182, "Long-term Follow-up of Patients With Chronic Kidney Disease Who Had Administered Cellgram-CKD in PMC-P-12 Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05096182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*